Navigation Links
Hospitals find Theraworx highly effective thwarting costly Urinary Tract Infections
Date:8/21/2013

ASHEVILLE, N.C., Aug. 21, 2013 /PRNewswire-iReach/ -- Data from multiple in-service clinical trials and research studies involving hundreds of patients using Theraworx™ at more than a dozen hospitals are showing positive results and signaling progress battling one of the most prevalent healthcare-associated infections (HAI), catheter-associated urinary tract infections, or CAUTI.  

Theraworx is an all-natural, skin-friendly topical solution that is applied for pre-insertion and post-catheter perineal cleaning, and incontinence skin care treatment.  It has become a key factor at medical facilities adopting a patient-focus safety strategy to address CAUTIs, the greatest single source of HAIs, costing U.S. hospitals $3 billion annually.

Some 900,000 patients a year develop a CAUTI while in U.S. hospitals, and 13,000+ patients die annually when bacteria from that infection enters the kidneys, making this an important patient safety issue.  A typical 165-bed hospital can incur more than $525,000 annually in costs to fight urinary tract infections.  Medicare does not pay hospitals for CAUTI readmissions, which can cost upwards of $10,000 or more per patient.

Notable progress
Over the past three years there has been extensive data analysis from trials of Theraworx in clinical settings.  Most notably, a large academic medical center in the Midwest conducted sequential 90-day trials covering more than 400 patients in its ICU and operating rooms.  Theraworx was used prior to Foley catheter insertion for peri-care and cleaning, achieving greater than 70 percent CAUTI reduction in each test period.

"Hospitals are realizing that if they initiate a proactive program to curb CAUTI and other infections with our proven protocol that they will see improvement quickly," said Steve Woody, president of Avadim LLC.  "This is particularly significant now due to Medicare readmission penalties, pay-for-performance metrics and HAI reporting requirements that bring quite punitive consequences."

IRB studies further validate Theraworx effectiveness
Two hospital-sponsored, clinical-use research studies, both evaluated and approved by the Institutional Review Board (IRB), will be published this year that document, in detail, the use of Theraworx with a new clinical protocol that drastically curbs CAUTI.  One IRB-approved study concluded recently at 300-bed medical/ surgical hospital in Kentucky, with results expected to be published in early fall.

Produced by Avadim LLC, Theraworx is non-CHG total body pH and hygiene management solution that supports the function of the skin's natural immune system. For peri-care, a single-use 2-pack of disposable cloths is easily added to catheter bundles providing a cost-cutting, yet highly effective solution. In addition, a companion non-aerosol foam or spray bottle of Theraworx is available to continue maintenance and post-discharge incontinence care.  For more information call 877-677-2723, visit http://www.theraworx.com or write to StopCAUTI@theraworx.com.

Media Contact: Jared Buckner, Avadim LLC, 877-677-2723, jared@Theraworx.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE Avadim LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Over 50% of “Best Heart Hospitals” in U.S. News & World Report Are Certified to Implant the SynCardia Total Artificial Heart
2. The Veterinary Cooperative (TVC) and Vet-Stem, Inc. Announce an Exclusive Partnership to Offer Regenerative Medicine and Stem Cell Therapy to Over 300 Member Hospitals
3. 7 SynCardia Certified Centers Honored Among “Best Children’s Hospitals” for Cardiology and Heart Surgery by U.S. News & World Report
4. Cases of Bed Bugs in Hospitals Hike, My Cleaning Products Recommends Non-Pesticide Bed Bug Spray to Counter Bed Bug Outbreak
5. lifeIMAGE Announces No-Cost Service for Hospitals to Give Patients Secure Access to Medical Imaging, Pledges Support for the Blue Button Initiative
6. American Journal of Infection Control Study Validates ATP Testing for Monitoring Sanitation in Hospitals; Charm Sciences Test Verified
7. University of College London Hospitals (UCLH) Selects GEO SCAN Medical as New Standard of Care for the Detection and Treatment of Prostate Cancer
8. Oxford University Hospitals NHS Trust and the Bodleian Libraries Select ClinicalKey
9. Top 10 “Best Children’s Hospitals” Include 3 Pediatric Centers Offering SynCardia Total Artificial Heart
10. The Spring 2012 MediSend Biomedical Repair Training Program™ Sends Graduating Biomedical Technicians to Hospitals Around the World
11. Narayana Hrudayalaya Hospitals Teams With Ascension Health Alliance to Build Health City at Grand Cayman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Germany and ... QGEN ; Frankfurt Prime Standard: QIA) today ... Targeted RNA Panels for gene expression profiling, expanding QIAGEN,s ... (NGS). The panels enable researchers to select from over ... changes and discover interactions between genes, cellular phenotypes and ...
(Date:2/11/2016)... 11, 2016  Dovetail Genomics™ LLC today announced that ... for a planned metagenomic genome assembly service. Richard ... genome assembly method in a talk on Friday, February ... Technology conference in Orlando, Fla. ... datasets is difficult. Using its proprietary Chicago ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... of its new stem cell treatment clinic in Quito, Ecuador. The new facility ... and trauma applications to patients from around the world. , The new ...
(Date:2/10/2016)... , Feb.10, 2016 ASAE is introducing ... Association Management Companies (AMC) the option of joining or ... annual fee determined by staff size, every employee in ... join ASAE and reap all available member benefits.   ... "Our new organizational membership options will allow organizations of ...
Breaking Biology Technology:
(Date:2/2/2016)... Feb. 2, 2016  Based on its recent ... Sullivan recognizes US-based Intelligent Retinal Imaging Systems (IRIS) ... Award for New Product Innovation. IRIS, a prominent ... North America , is poised to set ... diabetic retinopathy market. The IRIS technology presents superior ...
(Date:1/28/2016)... JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: SYNA ... results for its second quarter ended December 31, 2015. ... second quarter of fiscal 2016 increased 2 percent compared to the ... second quarter of fiscal 2016 was $35.0 million, or $0.93 per ... Non-GAAP net income for the first quarter of fiscal 2016 grew ...
(Date:1/22/2016)... 22, 2016 ... of the  "Global Behavioral Biometric Market ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ... Biometric Market 2016-2020"  report to their ... Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ...
Breaking Biology News(10 mins):